|
|||||||||||||||||||||||||||||||||||||||
Proliferation
of exogenously injected primordial germ cells (PGCs) into busulfan-treated
chicken embryos
H.
Furuta, N. Fujihara Animal
Resource Science Section, Division of Bioresource and Bioenvironmental
Sciences Graduate School Kyushu University, Fukuoka 812-8581, Japan Asian J Androl 1999 Dec; 1: 187-190 Keywords:
AbstractAim: This study was designed to investigate the effect of busulfan treatment on the proliferation of chicken primordial germ cells (PGCs) in vivo, focusing on the preferential settlement of PGCs onto the germinal ridges of chicken embryos. Methods: Busulfan (250 ng/egg) was injected into the egg white of freshly oviposited fertilized eggs, which were then incubated. Embryonic development and viability were examined, and exogenous PGCs collected from embryonic blood vessels were injected into the germinal crescent region of recipient embryos. The number of PGCs resided onto germinal ridges of the right and left sides were compared. Results: Busulfan had a slight harmful effect on the embryo viability and the PGCs proliferation. The number of PGCs resided onto the left side of germinal ridges was slightly higher as compared with the right side. Conclusion: Busulfan suppressed the viability of embryos and the proliferation of endogenous PGCs in the recipient embryos. However, the number of exogenous PGCs proliferated was higher in embryos treated with busulfan than those without busulfan. Data also suggest the possibility of a preferential residence of PGCs toward the left side of the germinal crescent region as compared with the right, which may be due to a more advanced functional development of the left gonad than the right.1 Introduction Chicken primordial germ cells (PGCs) are important resources to produce transgenic offspring[1] and successful transfer of exogenous genes to PGCs has been carried out with blastodermal cells[2,3]. It is a common technique to establish germ line chimeric chickens using PGCs transferred between embryonic blood vessels[4-8]. Recently, busulfan (1,4-butanediol dimethanesulfonate) has been often used to introduce exogenous PGCs into chicken embryos. The drug has been said to suppress the proliferation of PGCs in chicken[9-12]. The present study was designed to investigate the effect of busulfan treatment of fertilized eggs, and the migration and proliferation of PGCs subsequent to the drug treatment.2 Materials and methods 2.1
Experiment I In
this experiment, there were 4 Treatments. Treatment
1: Busulfan 625 g were dissolved in 100 mL of phosphate buffered saline
(PBS). A circular window about 1.0 cm in diameter was opened on the sharp
edge of the recipient eggs. Around 40 L of PBS solution containing 250
ng busulfan was injected into the egg white through the window just before
incubation. Embryonic blood samples were collected from vessels of the
embryos after 72 hours of
incubation (stage 12-15)[13]. Approximately 1.0 L blood was
smeared on a glass slide and the number of PGCs was then counted under
microscope after staining with PAS solution. Treatment
2: Embryonic blood samples were collected from the donor embryos incubated
for 72 hours (stage 12-15). The donor PGCs were isolated by the ficoll
density centrifugation method[13-15].
For recipient embryos, busulfan-treated eggs were
also incubated for 48 hours (stage 9-10) as in Treatment 1. Fifty to sixty donor
PGCs were introduced into the germinal crescent of recipient embryos through
the window. After an additional 24-hour incubation (stage 14-16), blood
samples were collected from the recipient embryos and PGCs number per
1 L blood was counted. Treatment
3: Donor PGCs were prepared as in Treatment 1; recipient eggs were prepared
without busulfan treatment. The introduction of PGCs from donor embryos
into recipient embryos and the subsequent procedures were the same as
in Treatment 2. Treatment
4: Control eggs without busulfan injection. Experimental procedures were
similar to those in Treatment 1. 2.2
Experiment II Donor
and recipient eggs were prepared as in Treatment 2 of Experiment I with
or without busulfan
injection. PGC proliferation in the recipient embryos with or without
busulfan treatment was compared. Donor PGCs isolated from the blood samples
were labeled with PKH26 red fluorescent cell linker (Sigma Aldrich Japan,
Tokyo) to distinguish the exogenous PGCs from the endogenous ones originated
from the recipient embryos. The labeled PGCs were introduced into the
germinal crescent of the recipient embryos, which were then incubated
for 4 more days (total incubation time: 6 days; stage 23-26). The labeled
donor PGCs at the region of germinal ridges of recipient embryos were
examined under microscope equipped with TE-FM-Epi-fluorescent attachment
(Nikon, Tokyo). 2.3
Statistical analysis 3 Results The
development of the control embryos was normal, displaying around 24 PGCs per
1.0 L of blood sample (Figure 1).
On the contrary, busulfan injection (Treatments 1 and 2) resulted in significantly
fewer numbers of PGCs as compared with those without drug treatment (Treatments
3 and 4) (Table 1). The viability of the embryos
in Treatments 3 and 4 was higher than those in Treatments 1 and 2 (P<0.05),
while no significant difference was observed in the viability of embryos
and the number of PGCs between the control and Treatment 3 (Table 1). Figure
1. PGCs at stage 12-15, stained with PAS. Bar indicates 50 m.
The
labeled donor PGCs introduced into the recipient embryos in Experiment
II could be found at the germinal ridges of the recipient embryos (Figure
2). It was shown that the exogenous PGCs presented preferential residence
toward the left side
of the germinal ridges in comparison with the right side (Table 2). Figure
2. PKH26-positive PGCs (stage 23-26) at recipient germinal ridge.
Bar indicates 50 m.
4 Discussion When
busulfan was injected into eggs, the viability of the treated embryos
was reduced significantly (P<0.05), and the number of endogenous
PGCs was also significantly lower (P<0.05) as compared with
the control embryos. In Treatment 2, a similar tendency was observed in
the proliferation of exogenously injected PGCs in recipient embryos. Busulfan
has been reported to suppress the viability of embryos and the proliferation
of PGCs in the recipient embryos[9-12]. In this experiment,
the number of exogenous PGCs proliferated in the germinal ridges of drug-treated
recipient embryos was higher than that in embryos without drug-treatent.
It is considered that proliferation of exogenous PGCs occurred successfully
in the embryos where
the endogenous PGCs proliferation was suppressed by busulfan. Injection
of exogenous PGCs into the embryonic blood vessel[4-8] appears
to be harmful to the
development of embryos. Interestingly, the present results suggest the
possibility of a preferential residence of PGCs toward the left side of
the germinal crescent region as compared with the right, which may be
due to a more advanced functional development of the left gonad than the
right. A slightly dominant development of the left gonad compared with
right one has generally been accepted in birds. 5 Acknowledgments The authors are grateful to Dr. T. Kuwana for his kindest guidance to collect avian PGCs from early embryos with special techniques, and also thanks the highly skilled technical assistance by Mr. Yoshihiro throughout the experiments. Special financial support was provided grant-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan, Japanese Society for the Promotion of Science (JSPS), Toyota Foundation, Sumitomo Foundation and Nissan Science Foundation. References [1]
Fujihara N. Poultry genetic resource and conservation biology. Jpn Poult
Sci 1999; 36: 124-47. Supported
by grant-in-aid for scientific research from the Ministry of Education,
Science and Culture of Japan, Japanese Society for the Promotion of Science
(JSPS), Toyota Foundation, Sumitomo Foundation and Nissan Science Foundation.
|
|||||||||||||||||||||||||||||||||||||||
![]() |